Alps Advisors Inc Instil Bio, Inc. Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $27,314 - $43,291	-5,874 Reduced 7.66%	70,827 $343,000
Q2 2022 Aug 11, 2022	SELL	$4.21 - $11.15 $235,806 - $624,522	-56,011 Reduced 42.2%	76,701 $354,000
Q1 2022 May 16, 2022	SELL	$8.48 - $18.1 $139,835 - $298,469	-16,490 Reduced 11.05%	132,712 $1.43 Million
Q4 2021 Feb 09, 2022	BUY	$15.37 - $22.5 $2.29 Million - $3.36 Million	149,202 New	149,202 $2.55 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $3.23B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.